Actelion: A booming start to the year
BUY, Fair Value CHF59 vs. CHF58 (+13%)
Actelion today reported very strong revenues and profits for the first quarter of 2013, driven by Tracleer (up 4% in local currencies) whose performance is somewhat boosted by exceptional and non-recurring items but also by a remarkable management of costs resulting in the end in an outstanding growth of core earnings by 44% to CHF168.5m. The bottom part of the P&L had nothing specific to report except a 14.8% tax rate, even lower than expected. Thus fully diluted EPS stands at CHF0.85 when consensus was expecting CHF0.60 and its higher-end CHF0.78. Although Actelion makes it clear that R&D and S&M expenses will increase over the year with phase III trials starting and the Opsumit launch and that Tracleer benefited from one-time positive items in Q1, the CFO also mentions that “it is possible that some of the forecasted profit growth for 2014 could be brought forward”.
Full report available to subscribers
Please contact firstname.lastname@example.org